Mindfulness-Based Substance Use Prevention (MINDS-UP) (MINDS-UP)

April 21, 2026 updated by: David Saunders, MD PhD, New York State Psychiatric Institute

Mindfulness-Based Substance Use Prevention (MINDS-UP): a Randomized Controlled Trial

The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The main questions it aims to answer are:

  1. Is MINDS-UP feasible and what is its preliminary efficacy?
  2. Are MRI protocol and procedures feasible?

An additional exploratory question is:

Are there neural and psychopathological mechanisms through which MINDS-UP might work?

Researchers will compare Sport - Prevention Plus Wellness (PPW) (an evidence based substance use prevention program) to Sport - Prevention Plus Wellness + MINDS-UP to examine the preliminary efficacy of MINDS-UP.

Participants will

  • take assessment #1
  • have 2 MRIs and take MINDS-UP, just take MINDS-UP or have a delayed start
  • take assessment #2
  • take PPW, a single remote and research assistant-delivered 45-minute session
  • take assessment #3
  • take assessment #4

Study Overview

Study Type

Interventional

Enrollment (Estimated)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Youth is ages 10-14 years on the day of screening [i.e., does not turn 15 before or on the day of screening]
  • Access to a smart phone, tablet, or computer with Wi-Fi
  • English-speaking

Exclusion Criteria:

  • Has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder.
  • Youth is actively involved in another Boricua Youth Study (BYS)
  • Youth's sibling is or has previously been enrolled in MINDS-UP.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Sport: Prevention Plus Wellness (PPW)
Sport: Prevention Plus Wellness (PPW) is a brief, evidence-based substance use prevention program for youth. PPW consists of a single remote-delivered 45-minute session by a research assistant (RA) trained in PPW that is interactive and intended for use by youth in the home setting. It involves screening youth to increase awareness of their current health behaviors; motivational enhancement for change; and establishing a behavior goal plan.
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.
Other Names:
  • PPW
Experimental: MINDS-UP with MRI + PPW
MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Half of those randomized to receive MINDS-UP + PPW (n=10) will receive functional and structural MRI before and after MINDS-UP to evaluate feasibility and acceptability of our MRI procedures and study design. Participants randomized to MINDS-UP with MRI arm will also complete PPW.
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.
Other Names:
  • PPW
MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.
Functional MRI to investigate preliminary neural mechanisms of MINDS-UP
Experimental: MINDS-UP without MRI + PPW
MINDS-UP consists of 4 x 60-minute sessions, once weekly over 4 weeks. MINDS-UP will be delivered to participants remotely, in a 1:1 setting, taught by the meditation teachers that will be hired and trained by Dr. Saunders. Additionally, participants will be provided audio files of 5-10-minute guided meditation practices, led by Dr. Saunders, as homework. Participants randomized to MINDS-UP without MRI arm will also complete PPW.
PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.
Other Names:
  • PPW
MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Teacher Rated Participation
Time Frame: Completion of Study (up to 36 months)
Research Assessment Package for Schools - Teacher Rated
Completion of Study (up to 36 months)
Acceptability
Time Frame: Completion of Study (up to 36 months)
Acceptability of Intervention Measure
Completion of Study (up to 36 months)
Retention
Time Frame: Completion of Study (up to 36 months)
Percent of participants who completed all study procedures among those who were randomized
Completion of Study (up to 36 months)
Attendance
Time Frame: Completion of Study (up to 36 months)
Percent of scheduled sessions that were completed by the participant.
Completion of Study (up to 36 months)
Homework Completion
Time Frame: Completion of Study (up to 36 months)
Percentage of assigned homeworks that were completed by the participant.
Completion of Study (up to 36 months)
Participation (student)
Time Frame: Completion of Study (up to 36 months)
Research Assessment Package for Schools - Student Engagement
Completion of Study (up to 36 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI retention
Time Frame: Completion of Study (up to 36 months)
Percentage of participants randomized to receive MRI that complete both MRIs
Completion of Study (up to 36 months)
Future MRI endorsement
Time Frame: Completion of Study (up to 36 months)
Percentage of participants who endorse willingness to undergo a future research MRI scan
Completion of Study (up to 36 months)
Anxiety and Depression
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains.
4-6 weeks, 6 months, and 12 months
Mindfulness
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness
4-6 weeks, 6 months, and 12 months
Externalizing Problems (parent-report)
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems
4-6 weeks, 6 months, and 12 months
Externalizing Problems (self-report)
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the externalizing problems subscale on the Youth Self Report, which is comprised of 112 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
4-6 weeks, 6 months, and 12 months
Total Problems (self-report)
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale Youth Self Report; the survey is comprised of 112 items, with individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
4-6 weeks, 6 months, and 12 months
Total Problems (parent-report)
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
4-6 weeks, 6 months, and 12 months
Cannabis Use
Time Frame: 4-6 weeks, 6 months, and 12 months
Cannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis.
4-6 weeks, 6 months, and 12 months
Alcohol sipping
Time Frame: 4-6 weeks, 6 months, and 12 months
Low-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip.
4-6 weeks, 6 months, and 12 months
Tobacco Use
Time Frame: 4-6 weeks, 6 months, and 12 months
Tobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use.
4-6 weeks, 6 months, and 12 months
ADHD Symptoms
Time Frame: 4-6 weeks, 6 months, and 12 months
Pre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems
4-6 weeks, 6 months, and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

August 15, 2024

First Submitted That Met QC Criteria

September 9, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on Prevention Plus Wellness

Subscribe